Spectrophotometric Determination of Lisinopril Drug by Oxidative Coupling Reaction with 4-aminonaphthalene-1- sulfonic acid Reagent
Article Sidebar
Main Article Content
Abstract
A simple, rapid and sensitive spectrophotometric method for determination of Lisinopril (LS) in both pure form and pharmaceutical preparations has been reported. The adapted technique based on utilization 4-aminonaphthalene-1-sulfonic acid as a Chromogenic reagent through an oxidative coupling reaction with Lisinopril and Potassium Peroxydisulfate (oxidation agent) in acidic medium to form green dye soluble product absorption maxima at 612 nm. Linearity was in the range 2–43 μg ml-1. The values of molar absorption coefficient (ε), correlation coefficient and Sandel’s index were found to be 10.3808 × 103 L. mole-1 cm-1, 0.9995 and 0.00343 µg.cm-2 respectively. The average of recovery % was 100.067. Detection Limit and quantitative limit were 0.0343 µg/ml and 0.1143 µg/ml. The proposed method has been successfully applied in the determination of preparations containing lisinopril.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] "Lisinopril Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 23 December 2018.
[2] "Lisinopril Use During Pregnancy". Drugs.com. 22 October 2019. Retrieved 27 February 2020.
[3] Fischer, Jnos; Ganellin, C. Robin Analogue-based Drug Discovery. John Wiley & Sons. p. 467. (2006).
[4] "Drug Approval Package: Qbrelis (lisinopril)". U.S. Food and Drug Administration (FDA). 29 July 2016. Retrieved 5 August 2020.
[5] "Lisinopril – Drug Usage Statistics". ClinCalc. 23 December 2019. Retrieved 7 April 2020.
[6] "Prinivil- lisinopril tablet". DailyMed. 4 November 2019. Retrieved 27 February 2020.
[7] Katzung, Bertram, Basic and Clinical Pharmacology. New York: McGraw Hill. pp. 175, 184–85. (2012).
[8] Sadat-Ebrahimi SR, Parnianfard N, Vahed N, Babaei H, Ghojazadeh M, Tang S, Azarpazhooh A "An evidence-based systematic review of the off-label uses of lisinopril". Br J Clin Pharmacol. 84 (11): 2502–21. (July 2018).
[9] "Summary of Product Characteristics (SmPC) – (emc)". Lisinopril 10mg Tablet. 13 November 2019. Retrieved 27 February 2020.
[10] "Lisinopril". Pub Chem. Retrieved 6 June 2018.
[11] Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ., p. 718. 2004.
[12] Derayea, Sayed M., Khalid M. Badr El-din, and Fatma F. Mohammed. "An innovative validated spectrofluorimetric method for determination of Lisinopril in presence of hydrochlorothiazide; application to content uniformity testing." Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 188. 318-323. 2018.
[13] Li, Yinhuan, Yankun Li, and Yun Yang. "Flow-Injection Chemiluminescence Determination of Lisinopril Using Luminol–KMnO 4 Reaction Catalyzed by Silver Nanoparticles. "Applied spectroscopy 65.4: 376-381.2011.
[14] Rajendraprasad, Nagaraju, and Kanakapura Basavaiah. "Development of membrane electrodes for selective determination of lisinopril in pharmaceuticals." Journal of Analytical Science and Technology: 1-14. 10.1 (2019).
[15] Ebeid, W., et al. "Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE). "Die Pharmazie - An International Journal of Pharmaceutical Sciences 70.6: 368-373. 2015.
[16] Adam, Elsadig HK. "Stress degradation studies on lisinopril dihydrate using modified reverse phase high performance liquid chromatography." American Journal of Analytical Chemistry 2014.
[17] Pasquini, Benedetta, et al. "Cyclodextrin-and solvent - modified micellar electrokinetic chromatography for the determination of captopril, hydrochlorothiazide and their impurities: a quality by design approach." Talanta 160: 332-339. (2016).
[18] Raza, Asad, and Tariq Mahmood Ansari. "Spectrophotometric determination of lisinopril in pure and pharmaceutical formulations." Journal of the Chinese Chemical Society 52.5: 1055-1059. (2005).
[19] Valezi, Camila Farinha, Ana Paula Pires Eisele, and Elen Romão Sartori. "Versatility of a carbon paste electrode coupled to differential pulse voltammetry for determination of lisinopril with its associations (hydrochlorothiazide and amlodipine)." Analytical Methods 9.31: 4599-4608. (2017).
[20] Mohammed, Fatma F., Khalid M. Badr El-Din, and Sayed M. Derayea. "Switch on fluorescence probe for the selective determination of lisinopril in pharmaceutical formulations: application to content uniformity testing." RSC advances 8.29: 16269-16277. (2018).